Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Giornale Italiano Di Cardiologia (2006)
|
February 3, 2026
[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy]
Federico Nardi, Giuseppe Patti, Giorgio Quadri, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
The American Journal of Cardiology
|
March 9, 2019
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study)
Fabrizio D'Ascenzo, Pierluigi Omedè, Ovidio De Filippo, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
The American Journal of Cardiology
|
January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations
Fabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
Circulation. Cardiovascular Interventions
|
February 28, 2020
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII Study
Luca Gaido, Fabrizio D'Ascenzo, Yoichi Imori, et al.
Thrombosis Research
|
June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Carme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology
|
April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)
Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Giornale Italiano Di Cardiologia (2006)
|
February 3, 2026
[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy]
Federico Nardi, Giuseppe Patti, Giorgio Quadri, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
The American Journal of Cardiology
|
March 9, 2019
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study)
Fabrizio D'Ascenzo, Pierluigi Omedè, Ovidio De Filippo, et al.
International Journal of Cardiology
|
September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
Fabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
The American Journal of Cardiology
|
January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations
Fabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
Circulation. Cardiovascular Interventions
|
February 28, 2020
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis From the RAIN-CARDIOGROUP VII Study
Luca Gaido, Fabrizio D'Ascenzo, Yoichi Imori, et al.
Thrombosis Research
|
June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Carme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology
|
April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)
Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Page
of 13